Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| HX002421-01 | Other Grant/Funding Number | VA HSR&D |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| NYU Langone Health | OTHER |
Not provided
Not provided
Not provided
Aim 1: Establish the feasibility of screening for hearing loss in the ED Aim 2: Determine the acceptability of the screening procedure (among the ED population) Aim 3: Derive a preliminary estimate of the effect size of primary outcomes Aim 4: Identify the evidence that decision makers in Veteran Affair Medical Centers, ED and Audiology Services need to commit to this approach
The goal of this study is to test whether providing hearing assistance devices to older age hearing impaired patients in the ED setting will improve in-ED understanding and preparation for discharge. The proposed intervention, the Hearing Impairment, Strategies and Outcomes in VA Emergency Departments (HearVA-ED) will be conducted in the Emergency Departments of the Manhattan and Brooklyn VAs of the New York Harbor Healthcare System and will recruit hearing impaired ED patients who are 60 years and older and have been admitted to the ED with a low acuity triage score indicating a high likelihood of discharge home. The investigators will identify hearing impairment by using the Hearing Handicap Inventory for the Elderly survey (HHIE-S). The investigators will randomize consenting patients who fail the screening to either receipt of a simple hearing assistance device (a "PockeTalkerTM") during their ED stay or usual care. The investigators will test whether the provision of a PockeTalkerTM is feasible in this environment (by measuring the amount of device use), whether providing the device improves self-reported quality of hearing and understanding during the ED stay, and whether use of the device improves the quality of preparation for post-discharge care. If this randomized controlled trial demonstrates beneficial effects for in-ED use of a simple hearing assistance device for hearing impaired patients, this strategy can be disseminated throughout the VA healthcare system.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention: PockeTalker | Experimental | Consenting participants will be randomly assigned to the intervention group while receiving care in the emergency department |
|
| Control: No PockeTalker | Other | Consenting participants will be randomly assigned to the control group while receiving care in the emergency department |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| PockeTalker | Other | The intervention group will receive PockeTalkers (hearing assistance devices) while they receive care in the ED |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants With Use of Hearing Assistance Device (HAD) During Emergency Department (ED) Stay | The investigators will observe and survey intervention participants to determine whether or not they use the hearing assistance device while they are in the ED. This will be measured on a yes/no basis. | Duration of ED stay, average of 1-2 days |
| Patient-Rated Quality of Hearing, Understanding, and Communication With Providers During ED Stay | Participants will self-rate their quality of hearing, understanding, and communication using a six item questionnaire. Scored on a 10-point Likert scale (1 = do not agree at all; 10 = completely agree) the questions will be: When I talked to the doctors and nurses today ... (1) their voices were very clear; (2) I was able to hear the sounds that I wanted to hear; (3) noises did not cause a problem for my hearing; and (4) listening did not make me tired. Two additional statements will explicitly capture understanding: (5) I was able to understand what they said; and (6) I was able to understand without making an effort. Higher scores will indicate better communication and understanding with providers. | Duration of ED stay, average of 1-2 days |
| Patient-Rated Quality of Post-Discharge Care | Patient-rated quality of post-discharge care using a three-item subset of the Care Transition Measure (CTM). The questions are scored on a 1-4 scale (1= strongly disagree; 4 = strongly agree): (1) The ED staff considered my preferences and those of my family or caregiver in deciding what my healthcare needs were for discharge; (2) Leaving the ED, I have a good understanding of the things I am responsible for in managing my health; (3) Leaving the ED, I clearly understand the purpose for each of my medications. Higher scores will indicate better discharge preparation. | At time of discharge from ED, average 1 day |
| Measure | Description | Time Frame |
|---|---|---|
| Education Level | The Investigators will code what education level the Veterans have completed. | Duration of ED stay, average of 1-2 days |
| Primary Language | The Investigators will code what language the Veterans speak when at home. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Joshua Chodosh, MD MSHS | VA NY Harbor Healthcare System, New York, NY | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| VA NY Harbor Healthcare System, New York, NY | New York | New York | 10010-5011 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Intervention: PockeTalker | Consenting participants will be randomly assigned to the intervention group while receiving care in the emergency department PockeTalker: The intervention group will receive PockeTalkers (hearing assistance devices) while they receive care in the ED |
| FG001 | Control: No PockeTalker | Consenting participants will be randomly assigned to the control group while receiving care in the emergency department No PockeTalker: The control group will not receive PockeTalkers while they receive care in the ED |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
The first phase of intervention, the Hearing Impairment, Strategies and Outcomes in VA Emergency Departments (HearVA-ED) was conducted in the Emergency Departments of the Manhattan and Brooklyn VAs of the New York Harbor Healthcare System and recruited hearing impaired ED patients who are 60 years and older and were admitted to the ED with a low acuity triage score indicating a high likelihood of discharge home.
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Intervention: PockeTalker | Consenting participants will be randomly assigned to the intervention group while receiving care in the emergency department PockeTalker: The intervention group will receive PockeTalkers (hearing assistance devices) while they receive care in the ED |
| BG001 | Control: No PockeTalker |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Number of Participants With Use of Hearing Assistance Device (HAD) During Emergency Department (ED) Stay | The investigators will observe and survey intervention participants to determine whether or not they use the hearing assistance device while they are in the ED. This will be measured on a yes/no basis. | Those randomized to receive the hearing assistance device, how many used the hearing assistance device in the ED | Posted | Count of Participants | Participants | Duration of ED stay, average of 1-2 days |
|
|
35 days post-discharge
The definition of an adverse event and/or serious adverse event, used to collect adverse event information does not differ from the clinical trial definitions.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Intervention | Veterans who received HAD in ED | 0 |
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Dr. Joshua Chodosh | VA NY Harbor Healthcare System | 212-686-7500 | 5043 | joshua.chodosh@va.gov |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot | Yes | No | No | Study Protocol | Oct 18, 2018 | Jan 27, 2021 | Prot_000.pdf |
| SAP | No | Yes | No | Statistical Analysis Plan | Apr 19, 2018 | Jan 27, 2021 | SAP_001.pdf |
Not provided
| ID | Term |
|---|---|
| D034381 | Hearing Loss |
| D003142 | Communication |
| ID | Term |
|---|---|
| D006311 | Hearing Disorders |
| D004427 | Ear Diseases |
| D010038 | Otorhinolaryngologic Diseases |
| D012678 | Sensation Disorders |
Not provided
Not provided
Consenting participants will be randomly assigned to the control or intervention arm of the study. Participants in the intervention arm will receive PockeTalkers (hearing assistance devices) for the duration of their time in the emergency department. Participants in the control group will not receive hearing assistance devices during their time in the emergency department.
Not provided
Not provided
Not provided
Not provided
| No PockeTalker | Other | The control group will not receive PockeTalkers while they receive care in the ED |
|
| Duration of ED stay, average of 1-2 days |
| Number of Participants Who Live Alone or With Others | The Investigators will code whether the Veteran lives with others or alone. | Duration of ED stay, average of 1-2 days |
| Number of Participants in the ED Alone or With Others | The Investigators will code whether the Veteran came to the ED with others or alone. | Duration of ED stay, average of 1-2 days |
| Hospital Readmission | The Investigators will determine whether patients have had an ED revisit within three and 30 days through CPRS review as well as a brief follow-up phone call four and 35 days after ED discharge. | 3-30 days after initial ED stay |
Consenting participants will be randomly assigned to the control group while receiving care in the emergency department No PockeTalker: The control group will not receive PockeTalkers while they receive care in the ED |
| BG002 | Total | Total of all reporting groups |
| Participants |
|
| Age, Continuous | Mean | Standard Deviation | years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Ethnicity (NIH/OMB) | Count of Participants | Participants |
|
| Race/Ethnicity, Customized | Count of Participants | Participants |
|
| Region of Enrollment | Count of Participants | Participants |
|
| Education Level | Count of Participants | Participants |
|
| Primary Language | Count of Participants | Participants |
|
| Counts |
|---|
| Participants |
|
|
| Primary | Patient-Rated Quality of Hearing, Understanding, and Communication With Providers During ED Stay | Participants will self-rate their quality of hearing, understanding, and communication using a six item questionnaire. Scored on a 10-point Likert scale (1 = do not agree at all; 10 = completely agree) the questions will be: When I talked to the doctors and nurses today ... (1) their voices were very clear; (2) I was able to hear the sounds that I wanted to hear; (3) noises did not cause a problem for my hearing; and (4) listening did not make me tired. Two additional statements will explicitly capture understanding: (5) I was able to understand what they said; and (6) I was able to understand without making an effort. Higher scores will indicate better communication and understanding with providers. | Posted | Number | Percent of participants | Duration of ED stay, average of 1-2 days |
|
|
|
| Primary | Patient-Rated Quality of Post-Discharge Care | Patient-rated quality of post-discharge care using a three-item subset of the Care Transition Measure (CTM). The questions are scored on a 1-4 scale (1= strongly disagree; 4 = strongly agree): (1) The ED staff considered my preferences and those of my family or caregiver in deciding what my healthcare needs were for discharge; (2) Leaving the ED, I have a good understanding of the things I am responsible for in managing my health; (3) Leaving the ED, I clearly understand the purpose for each of my medications. Higher scores will indicate better discharge preparation. | Posted | Number | percentage of participants who agree | At time of discharge from ED, average 1 day |
|
|
|
| Secondary | Education Level | The Investigators will code what education level the Veterans have completed. | Posted | Count of Participants | Participants | Duration of ED stay, average of 1-2 days |
|
|
|
| Secondary | Primary Language | The Investigators will code what language the Veterans speak when at home. | Posted | Count of Participants | Participants | Duration of ED stay, average of 1-2 days |
|
|
|
| Secondary | Number of Participants Who Live Alone or With Others | The Investigators will code whether the Veteran lives with others or alone. | Posted | Count of Participants | Participants | Duration of ED stay, average of 1-2 days |
|
|
|
| Secondary | Number of Participants in the ED Alone or With Others | The Investigators will code whether the Veteran came to the ED with others or alone. | Posted | Count of Participants | Participants | Duration of ED stay, average of 1-2 days |
|
|
|
| Secondary | Hospital Readmission | The Investigators will determine whether patients have had an ED revisit within three and 30 days through CPRS review as well as a brief follow-up phone call four and 35 days after ED discharge. | The Investigators will determine whether patients have had an ED revisit within three and 30 days through CPRS review as well as a brief follow-up phone call four and 35 days after ED discharge at the conclusion of phase 2 of the project. | Posted | Number | percentage of participants | 3-30 days after initial ED stay |
|
|
|
| 66 |
| 0 |
| 66 |
| 0 |
| 66 |
| EG001 | Control | Veterans who did not receive HAD in ED | 0 | 67 | 0 | 67 | 0 | 67 |
Not provided
Not provided
Not provided
| D009461 |
| Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001519 | Behavior |
| 3. Noises did not cause a problem for my hearing. |
|
| 4. Listening did not make me tired. |
|
| 5. I was able to understand what they said. |
|
| 6. I was able to understand without making an effort. |
|
| 3. When leaving, I clearly understood the purpose for taking each of my medications. |
|
| Education: Completed college |
|
| Education: Some college |
|
| Other |
|